Published date: 11 November 2022
This notice was replaced on 11 November 2022
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Future opportunity (published 11 November 2022, last edited 5 December 2022)
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£74,000,000
Procurement reference
CF-1181100D0O000000rwimUAA
Published date
11 November 2022
Approach to market date
1 May 2023
Contract start date
1 December 2023
Contract end date
30 November 2024
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
CM/PHR/22/5693 NHS National Proprietary Pharmaceuticals - Eculizumab biosimilar
About the buyer
Contact name
Branded Team
Address
Rutland House
Runcorn
WA7 2ES
UK
Share this notice
All content is available under the
